Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aemetis (AMTX) Research & Development (2016 - 2023)

Aemetis (AMTX) has 12 years of Research & Development data on record, last reported at $37000.0 in Q4 2023.

  • For Q4 2023, Research & Development fell 9.76% year-over-year to $37000.0; the TTM value through Dec 2023 reached $152000.0, down 15.56%, while the annual FY2023 figure was $152000.0, 15.56% down from the prior year.
  • Research & Development reached $37000.0 in Q4 2023 per AMTX's latest filing, up from $36000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $117000.0 in Q1 2020 and bottomed at $21000.0 in Q2 2020.
  • Average Research & Development over 5 years is $41900.0, with a median of $37000.0 recorded in 2019.
  • Peak YoY movement for Research & Development: surged 254.55% in 2020, then plummeted 80.34% in 2021.
  • A 5-year view of Research & Development shows it stood at $45000.0 in 2019, then decreased by 15.56% to $38000.0 in 2020, then crashed by 42.11% to $22000.0 in 2021, then surged by 86.36% to $41000.0 in 2022, then dropped by 9.76% to $37000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Research & Development were $37000.0 in Q4 2023, $36000.0 in Q3 2023, and $37000.0 in Q2 2023.